01—Abstract
Summary
Summary of the 10-K filed March 2, 2009. Cited figures are marked; the original filing is the authoritative source.
IDEX Corporation, a Delaware corporation, describes itself as an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products.
For 2008, net sales were $1,489.5 milliona, up 10% from $1,358.6 million in 2007. Acquisitions made since 2007 contributed 9 percentage points of growth, foreign currency translation 1%, and organic sales were flat. Operating income fell 17% to $212.4 million, reflecting an $30.1 million goodwill impairment at Fluid Management Americas and $18.0 million of restructuring expenses.
Diluted EPS from continuing operations was $1.60b, down from $1.90 in 2007, and net income was $131.4 million versus $155.1 million. The balance sheet grew with acquisitions. Total assets were $2,176.3 million, goodwill $1,167.1 million and intangible assets $303.2 million.
Total borrowings rose to $554.0 millionc from $454.7 million, and borrowings as a percent of capitalization increased to 32.2% from 28.1%. The company reported working capital of $286.0 million and a current ratio of 2.3 to 1, and operating cash flow from continuing operations was $224.1 million. Management stated the company had not experienced liquidity issues and expected liquidity to be sufficient over the next twelve months.
Capital expenditures were $27.8 milliond, and the company repurchased 2.3 million shares for $50.0 million under a $125.0 million authorization. Investors should weigh the flat organic growth, the margin compression from gross margin falling to 40.5% from 41.8%, and the Dispensing Equipment segment's operating loss of $10.6 million against the company's acquisition-driven expansion. The filing also notes a $1.2 million-scale sensitivity to a 50 basis point interest rate move on floating debt, and that two Fluid & Metering Technologies reporting units carrying $204.2 million of goodwill could face impairment if fair value fell 10%.
02—Key points
Key Highlights
- Net sales rose 10% to $1,489.5 million in 2008, with acquisitions contributing 9 points and organic sales flat.
- Operating income declined 17% to $212.4 million, including a $30.1 million goodwill impairment and $18.0 million in restructuring expenses.
- Diluted EPS from continuing operations was $1.60, compared with $1.90 in 2007; net income was $131.4 million versus $155.1 million.
- Gross margin fell to 40.5% from 41.8%, attributed to product mix, higher material costs and recent acquisitions.
- Total borrowings increased to $554.0 million from $454.7 million, and borrowings as a percent of capitalization rose to 32.2% from 28.1%.
- Operating cash flow from continuing operations was $224.1 million; the company repurchased $50.0 million of stock during 2008.
- Dispensing Equipment posted an operating loss of $10.6 million, while Fluid & Metering Technologies generated $129.4 million of operating income.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2008, Idex kept $0.09.
- Revenue$1.49B100.0%
- Cost of revenue−$892.0M59.9%
- Gross profit$597.4M40.1%
- Operating costs−$391.5M26.3%
- Operating income$206.0M13.8%
- Interest, other & tax−$78.9M5.3%
- Net income$127.0M8.5%
Where FY2008 revenue went
$1.49B- Cost of revenue: $892.0M, 60% of revenue
- SG&A: $343.4M, 23% of revenue
- Net income: $127.0M, 8.5% of revenue
- Other operating costs: $48.1M, 3.2% of revenue
- Interest, other & tax: $78.9M, 5.3% of revenue
Kept 8.5% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2008filed March 2, 2009Financial Statements
| Revenue | $1.49B |
| Cost of Revenue | $892.04M |
| Gross Profit | $597.43M |
| SG&A Expenses | $343.39M |
| Operating Income | $205.96M |
| Interest Expense | $18.85M |
| Net Income | $127.03M |
| EPS (Basic) | $1.55 |
| EPS (Diluted) | $1.53 |
| Shares Outstanding (Basic) | 81.12M |
| Shares Outstanding (Diluted) | 82.32M |
05—Questions
Frequently Asked Questions
How did IDEX perform in 2008 compared with 2007?
Net sales grew 10% to $1,489.5 million, but organic sales were flat. Growth came mainly from seven acquisitions made since 2007. Operating income fell 17% to $212.4 million, and diluted EPS from continuing operations declined to $1.60 from $1.90.
What caused the decline in operating income?
The company recorded a $30.1 million goodwill impairment at Fluid Management Americas, a reporting unit in the Dispensing Equipment segment, and $18.0 million of restructuring expenses. Lower gross margin and acquisition-related expenses also contributed.
How is the company's debt position and liquidity?
Total borrowings were $554.0 million at December 31, 2008, up from $454.7 million a year earlier. The company reported working capital of $286.0 million, a current ratio of 2.3 to 1, and said it was in compliance with its two financial covenants and expected liquidity to be sufficient for the next twelve months.
What are the main risks identified in the filing?
Key risks include the effect of the financial crisis on customers and suppliers, international operations (47% of 2008 sales were outside the U.S.), foreign currency exposure to the Euro, Canadian Dollar, British Pound and Chinese Renminbi, interest rate exposure on $204.0 million of unhedged floating-rate debt, and the possibility of further goodwill impairments.
What is the company's capital return activity?
The Board authorized up to $125.0 million in share repurchases in April 2008. As of December 31, 2008, the company had bought 2.3 million shares for about $50.0 million. Cash dividends declared were $.48 per share for 2008.
06—Continue